doi: 10.1530/EC-23-0005 PMID: 37159343 Pronunciation: kan-a-gli-FLOE-zin Dapagliflozin (Farxiga ) Trade Names: Farxiga (Forxiga in Europe) Drug Class: Anti-diabetic drug, Hypoglycemic, SGLT-2 inhibitor, Gliflozin Pharmacology is similar to canagliflozin, the other SGLT-2 inhibitor in this drug class Mechanism of Action: Hypoglycemic : Inhibits the Na-glucose co-transporter 2 (SGLT-2) in the kidney to reduce glucose reabsorption, resulting in increased urinary glucose excretion, and lower plasma glucose
Microdosing is typically best for clients who want steady maintenance, long-term wellness, and consistent energy
Safely Using Sharps at Home, at Work and on Travel U.S
Proactive supplementation prevents deficits from developing
The activity of sodium-glucose-co-transporter-2 (SGLT2) inhibitors induces a change in microbiome diversity, leading to increased GLP-1 production from bacterial-produced post-biotics, noticeably those of tryptophan metabolism [147]
MOTS-c is added at Week 5 at 5 mg, 2-3 times per week